Cervical cancer treatment switch leads to 'biggest discovery in 20 years'

日本 ニュース ニュース

Cervical cancer treatment switch leads to 'biggest discovery in 20 years'
日本 最新ニュース,日本 見出し
  • 📰 MetroUK
  • ⏱ Reading Time:
  • 17 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 82%

The results could chance cancer treatment forever.

A course of chemotherapy before traditional cervical cancer treatment has shown incredible success A simple change to cervical cancer treatment using drugs that have already been approved has shown the biggest improvement in survival rates in almost 25 years, a new study has found. Cervical cancer is most commonly diagnosed in women in their early 30s, with around 3,200 new cases annually in the UK, meaning the new treatment could save hundreds of lives every year.

Cervical cancer is often caused by human papilloma virus Over 10 years, 500 patients took part in the Interlace trial at hospitals in the UK, Mexico, India, Italy and Brazil. They had been diagnosed with cervical cancer which was large enough to be seen without a microscope but had not spread to other parts of the body.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

MetroUK /  🏆 13. in UK

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

Trial results suggest better use of existing drugs increases cervical cancer survival and reduces recurrenceTrial results suggest better use of existing drugs increases cervical cancer survival and reduces recurrenceThe INTERLACE phase III trial assessed whether a short course of induction chemotherapy (IC) prior to chemoradiation (CRT) could reduce the rate of relapse and death among patients with locally advanced cervical cancer.
続きを読む »

Drugs can help to reduce cervical cancer death risk by over a third, study showsDrugs can help to reduce cervical cancer death risk by over a third, study showsResearch has been carried out by University College London's Cancer Institute.
続きを読む »

Short course of induction chemotherapy can reduce cervical cancer relapse and death by 35%Short course of induction chemotherapy can reduce cervical cancer relapse and death by 35%The INTERLACE phase III trial, funded by Cancer Research UK and UCL Cancer Trials Centre, assessed whether a short course of induction chemotherapy (IC) prior to chemoradiation (CRT) could reduce the rate of relapse and death among patients with locally advanced cervical cancer.
続きを読む »

Mum has 12-hour baths to treat agonising topical steroid withdrawalMum has 12-hour baths to treat agonising topical steroid withdrawal'I’m embracing my skin, I tell it every day how much I love it and how beautiful it has become.'
続きを読む »

Mum has 12-hour baths to treat agonising topical steroid withdrawalMum has 12-hour baths to treat agonising topical steroid withdrawal'I’m embracing my skin, I tell it every day how much I love it and how beautiful it has become.'
続きを読む »



Render Time: 2025-04-08 23:08:32